Tissue engineering is a rapidly growing scientific field that uses cell and/or cell combinations with biomaterials and/or biologically active molecules to create, repair, and/or replace cells, tissues, and organs. It aids in the production of materials that closely resemble the body's native tissue/tissues. Current medicines have been revolutionized as a result of tissue engineering, and the quality of life for millions of patients has improved. TE, although its many promises, has a number of limitations; translating these concepts into reality appears to be a difficult undertaking. One of the barriers is the inability of artificial materials to match the natural characteristics of tissues. This problem could be solved via nanotechnology and tailored nanoparticle engineering. This problem could be solved via nanotechnology and tailored nanoparticle engineering. Nanoparticles are distinguished by their nanoscale dimension, which allows them to develop important physical and chemical properties that improve their performance and hence make them useful in a variety of applications. Nanoparticles have just lately been employed in TE in order to increase mechanical and biological performance. Nanoparticles have an advantage in TE because of their small size and high surface-to-volume ratio, which is equivalent to peptides and small proteins. They are quickly absorbed by cells due to their ability to diffuse across membranes.
Title : Side effect free cancer chemotherapy by directed gene delivery using nanomaterials
A C Matin, Stanford University School of Medicine, United States
Title : Artificial intelligence (AI) in biomedical engineering
Hossein Hosseinkhani, Innovation Center for Advanced Technology, Matrix HT, United States
Title : Novel gene therapy options for pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Challenges in skeletal tissue engineering
Patrizia Ferretti, UCL Great Ormond Street Institute of Child Health, United Kingdom
Title : Electroactive polymer-based smart scaffolds for tissue engineering and regenerative medicine
Federico Carpi, University of Florence, Italy
Title : Cellular and molecular profiling of critical bone fractures in axolotl
Polikarpova Anastasia, The Institute of Molecular Pathology, Austria